| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 04/06/1995 | WO1995009182A1 Protective antigens against parasites |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995006744A3 Methods of suppressing immune response by gene therapy |
| 04/06/1995 | WO1995006718A3 Methods of suppressing autoimmune response |
| 04/06/1995 | WO1995006717A3 Methods of suppressing graft rejection |
| 04/06/1995 | CA2173218A1 Method for mammalian cell separation from a mixture of cell populations |
| 04/06/1995 | CA2172997A1 Insulin-secreting cell lines, methods of production and use |
| 04/06/1995 | CA2172547A1 Expression of human d4 dopamine receptors in stable cell lines |
| 04/06/1995 | CA2172492A1 Protective antigens against parasites |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2171553A1 Using antisense oligonucleotides to modulate nerve growth and to reverse .beta./a4 amyloid-induced morphology |
| 04/05/1995 | EP0646793A2 Methods for utilizing cell lines which lack human class II histocompatibility antigens |
| 04/05/1995 | EP0646646A2 Protein expression system |
| 04/05/1995 | EP0646600A1 A cell growth-inhibiting protein |
| 04/05/1995 | EP0646171A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes |
| 04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
| 04/05/1995 | EP0646124A1 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor |
| 04/05/1995 | EP0646013A1 Platelet derived growth factor antagonists |
| 04/05/1995 | EP0646010A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression |
| 04/05/1995 | EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 04/05/1995 | EP0507839B1 Method of separating haemopoietic progenitor cells |
| 04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
| 04/05/1995 | CN1028114C Monoclonal antibody specific for adhesion function domain of phagocyte surface protein |
| 04/04/1995 | US5403834 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/04/1995 | US5403750 Biocompatible, low protein adsorption affinity matrix |
| 04/04/1995 | US5403735 Object repeatedly captured at two different magnifications to derive measure of change of the object with time, and thus change of cell activity |
| 04/04/1995 | US5403734 t-PA with growth factor domain substitutions |
| 04/04/1995 | US5403581 Administering immunogenic polypeptide to poultry |
| 03/31/1995 | CA2132937A1 Protein expression system |
| 03/30/1995 | WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof |
| 03/30/1995 | WO1995008630A1 Surface loop structural analogues of fibroblast growth factors |
| 03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 03/30/1995 | WO1995008627A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
| 03/30/1995 | WO1995008621A1 Lipid-modified serum free media |
| 03/30/1995 | WO1995008570A1 Chimeric proteins which block complement activation |
| 03/30/1995 | WO1995008569A1 NOVEL PROTEIN sp38 AND CONTRACEPTIVE VACCINE |
| 03/30/1995 | WO1995008554A1 Nf-at polypeptides and polynucleotides |
| 03/30/1995 | WO1995008346A1 A method for the biological control of pollen in plants |
| 03/30/1995 | WO1995008262A1 Method for encouraging secondary somatic embryogenesis and application to the regeneration of plants, in particular the grape vine |
| 03/30/1995 | WO1995008261A1 Method for encouraging plant cell differentiation and plant thereby obtained |
| 03/30/1995 | WO1995005472A3 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants |
| 03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 03/30/1995 | CA2172610A1 Chimeric proteins which block complement activation |
| 03/30/1995 | CA2172540A1 Method for the biological control of pollen in plants |
| 03/30/1995 | CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 03/30/1995 | CA2172287A1 Nf-at polypeptides and polynucleotides |
| 03/30/1995 | CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof |
| 03/30/1995 | CA2171206A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
| 03/29/1995 | EP0645453A2 Alcohol de hydrogenase, DNA encoding it, preparation and method of preparing optically active alcohols |
| 03/29/1995 | EP0645147A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
| 03/29/1995 | EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
| 03/29/1995 | EP0644946A1 Vector particles resistant to inactivation by human serum |
| 03/29/1995 | EP0644939A1 Protein kinase c (iota) |
| 03/29/1995 | EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/29/1995 | EP0644930A1 Monoclonal antibody against the extra-villous trophoblast |
| 03/29/1995 | EP0644929A1 System and method for transplantation of cells |
| 03/29/1995 | EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses |
| 03/29/1995 | EP0644899A1 Production of recombinant human lactoferrin |
| 03/29/1995 | EP0644781A1 Tissue equivalents |
| 03/29/1995 | EP0644774A1 Improved production of reproductive hormones |
| 03/29/1995 | EP0620847A4 Preparation of pure cultures of post-mitotic human neurons. |
| 03/29/1995 | EP0460190B1 Method for detecting malignant diseases |
| 03/29/1995 | EP0374162B1 Balanced constitutive inducible transcription system |
| 03/29/1995 | EP0332667B1 Vector for integration site independent gene expression in mammalian host cells |
| 03/29/1995 | CN1028036C Tech. of strain breeding for growing Chinese cabbage of 100% sterile group by histological culture process |
| 03/28/1995 | US5401832 Brain derived and recombinant acidic fibroblast growth factor |
| 03/28/1995 | US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment |
| 03/28/1995 | US5401653 Method for culturing insect cells in a medium containing fish serum |
| 03/28/1995 | US5401635 Nucleic acids encoding human prohibitin mutants and detection thereof |
| 03/28/1995 | US5401629 Assay methods and compositions useful for measuring the transduction of an intracellular signal |
| 03/28/1995 | US5401627 Warts, cancer |
| 03/28/1995 | CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response |
| 03/28/1995 | CA2012631C Process for the production of hetero-bispecific antibodies |
| 03/28/1995 | CA1334942C Production of m-csf |
| 03/23/1995 | WO1995008115A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 03/23/1995 | WO1995008105A1 Method for obtaining a cell population enriched in stem cells and compositions derived therefrom |
| 03/23/1995 | WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto |
| 03/23/1995 | WO1995007994A2 Recombinant alphavirus vectors |
| 03/23/1995 | WO1995007992A2 Cloned glutamic acid decarboxylase |
| 03/23/1995 | WO1995007984A1 Human receptor h4-1bb |
| 03/23/1995 | WO1995007983A1 Human mu opioid receptor |
| 03/23/1995 | WO1995007982A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family |
| 03/23/1995 | WO1995007935A1 cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE |
| 03/23/1995 | WO1995007933A1 Methods and composition for the modulation of host immune response to allergens |
| 03/23/1995 | WO1995007707A1 Alteration of immune response using pan dr-binding peptides |
| 03/23/1995 | WO1995007706A1 The semaphorin gene family |
| 03/23/1995 | WO1995007704A1 Process for the stabilisation and long-term conservation of red blood cells |
| 03/23/1995 | WO1995005467A3 Chitinase, dna coding therefor and plants containing same |
| 03/23/1995 | WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 03/23/1995 | WO1994029469A3 Plasmids suitable for gene therapy |
| 03/23/1995 | CA2171951A1 Method for obtaining a cell population enriched in stem cells and compositions derived therefrom |
| 03/23/1995 | CA2171739A1 Human mu opioid receptor |
| 03/23/1995 | CA2171610A1 Cdna encoding a novel human protein tyrosine phosphatase |
| 03/23/1995 | CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 03/23/1995 | CA2170405A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family |
| 03/22/1995 | EP0643974A1 Vaccine against lyme disease |
| 03/22/1995 | EP0643769A1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II |
| 03/22/1995 | EP0643726A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |